These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23128119)

  • 1. Aldosterone blockade: the heart versus the kidney.
    Bhandari S
    Kidney Int; 2012 Nov; 82(10):1136; author reply 1136-7. PubMed ID: 23128119
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms.
    Shavit L; Lifschitz MD; Epstein M
    Kidney Int; 2012 May; 81(10):955-968. PubMed ID: 22336987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes in Dialysis Patients: Prospects for Improvement with Aldosterone Receptor Antagonists.
    Suthar SD; Middleton JP
    Semin Dial; 2016; 29(1):52-61. PubMed ID: 26242304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety.
    Bomback AS
    Blood Purif; 2016; 41(1-3):166-70. PubMed ID: 26765793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients.
    Mark PB; Taylor AH; McQuarrie EP; Jardine AG
    Semin Dial; 2014; 27(4):328-32. PubMed ID: 24499322
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade.
    Dawson A; Davies JI; Struthers AD
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention?
    Wenzel U
    Kidney Int; 2007 Mar; 71(5):374-6. PubMed ID: 17315004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor antagonists for heart failure.
    Funder J
    Expert Opin Pharmacother; 2011 Dec; 12(18):2767-9. PubMed ID: 22098225
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldosterone blockade in cardiovascular disease.
    Struthers AD
    Heart; 2004 Oct; 90(10):1229-34. PubMed ID: 15367532
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldosterone blockade: an emerging strategy for abrogating progressive renal disease.
    Epstein M
    Am J Med; 2006 Nov; 119(11):912-9. PubMed ID: 17071154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone blockade and heart failure.
    Jessup M
    N Engl J Med; 2003 Apr; 348(14):1380-2. PubMed ID: 12668698
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.
    Bomback AS; Klemmer PJ
    Am J Nephrol; 2009; 30(2):140-6. PubMed ID: 19299892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease.
    Hassan M; Qureshi W; Sroujieh LS; Albashaireh D; BouMalham S; Liroff M; Amjad W; Khalid F; Hadid H; Alirhayim Z
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):278-85. PubMed ID: 25002131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone antagonists in heart failure.
    Guglin M; Kristof-Kuteyeva O; Novotorova I; Pratap P
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):150-9. PubMed ID: 21160084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone target organ protection by eplerenone.
    Rudolph AE; Rocha R; McMahon EG
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone blockade in chronic kidney disease.
    Hirsch JS; Drexler Y; Bomback AS
    Semin Nephrol; 2014 May; 34(3):307-22. PubMed ID: 25016401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking aldosterone in heart failure.
    Shafiq MM; Miller AB
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mineralocorticoid receptor antagonists in chronic kidney disease - pros and cons].
    Jędras M; Filipowicz E
    Wiad Lek; 2017; 70(6 pt 2):1205-1208. PubMed ID: 29533915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone, organ damage and dietary salt.
    Catena C; Colussi G; Sechi LA
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):922-8. PubMed ID: 23803228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic kidney disease: do aldosterone antagonists help?].
    Rump LC
    Dtsch Med Wochenschr; 2014 Nov; 139(45):2274. PubMed ID: 25350238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.